CalciMedica
CALC

CalciMedica (CALC) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
GuggenheimInitiated CoverageBuy$9.00Aug 20, 2026
OppenheimerMaintainedOutperform$10.00 from $20.00Mar 5, 2026
HC Wainwright & Co.DowngradedBuy → NeutralJan 29, 2026
HC Wainwright & Co.MaintainedBuy$16.00May 15, 2025
HC Wainwright & Co.MaintainedBuy$16.00Apr 1, 2025
HC Wainwright & Co.MaintainedBuy$16.00Mar 4, 2025
LUCID CAPITAL MARKETSInitiated CoverageBuy$13.00Dec 17, 2024
HC Wainwright & Co.MaintainedBuy$16.00Nov 14, 2024
HC Wainwright & Co.MaintainedBuy$16.00 from $20.00Nov 4, 2024
HC Wainwright & Co.MaintainedBuy$20.00Aug 13, 2024
OppenheimerMaintainedOutperform$20.00 from $14.00Jul 10, 2024
HC Wainwright & Co.MaintainedBuy$20.00Jul 9, 2024
HC Wainwright & Co.MaintainedBuy$20.00Jun 27, 2024
HC Wainwright & Co.MaintainedBuy$20.00May 14, 2024
HC Wainwright & Co.MaintainedBuy$20.00Apr 1, 2024
OppenheimerMaintainedOutperform$14.00Apr 1, 2024
HC Wainwright & Co.MaintainedBuy$20.00Mar 13, 2024
JonesTradingInitiated CoverageBuy$22.00Feb 16, 2024
HC Wainwright & Co.MaintainedBuy$20.00Feb 13, 2024
HC Wainwright & Co.Initiated CoverageBuy$20.00Jan 29, 2024

Frequently asked questions

  • What is the latest analyst rating on CALC?

    On Aug 20, 2026, Guggenheim initiated coverage of CalciMedica at Buy with a price target of $9.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.